Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
01/19/2005 | EP1496924A2 Treatment of gastroparesis |
01/19/2005 | EP1496920A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation |
01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
01/19/2005 | EP1496914A1 (20S)-1a-HYDROXY-2a-METHYL AND 2&bgr;-METHYL-19-NOR-VITAM IN D sb 3 /sb AND THEIR USES |
01/19/2005 | EP1496910A1 Kinase inhibitors |
01/19/2005 | EP1496904A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
01/19/2005 | EP1496897A1 Tyrosine kinase inhibitors |
01/19/2005 | EP1496894A1 Angiogenesis inhibitors |
01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
01/19/2005 | EP1496890A1 Substituted beta-aminoalcohols used as medicaments |
01/19/2005 | EP1496883A1 Method for treating ileus with an alpha-ketoalkanoic acid, ester or amide |
01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
01/19/2005 | EP1496851A1 Oral care products containing ovomucin |
01/19/2005 | EP1496838A2 Substituted amides |
01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
01/19/2005 | EP1124562B1 Combination therapy to treat hepatitis b virus |
01/19/2005 | EP0545946B1 Growth-promoting agent |
01/19/2005 | CN1568365A Composition comprising a lactobacillus pentosus strain and uses thereof |
01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
01/19/2005 | CN1566154A Novel hepatocyte growth factor, preparing process and application thereof |
01/19/2005 | CN1566151A Sugar latticeing material CHB extracted from serum of turtle or/and tortoise, preparation process and application in pharmacy thereof |
01/19/2005 | CN1566131A Small interference RNA molecule SiRNA capable of attacking human hepatitis B virus and application thereof |
01/19/2005 | CN1566118A Antiviral activity possessed compound and preparation method thereof |
01/19/2005 | CN1565626A Nutrient agent |
01/19/2005 | CN1565618A Nutrient healthy powder for delaying senescence |
01/19/2005 | CN1565616A Preparation method of antidiarrheal medicine |
01/19/2005 | CN1565613A Chinese medicinal composition for treating acute pharyngitis and gingivitis and preparing method thereof |
01/19/2005 | CN1565601A Application of sichuan lovage rhizome oil by supercritical CO2 extraction method in pharmacy |
01/19/2005 | CN1565598A 'Calculi eliminating powder(capsule) |
01/19/2005 | CN1565592A Pharmaceutical formulation for treating digestive disease of animal or human and its preparing method |
01/19/2005 | CN1565591A Preparation and usage of |
01/19/2005 | CN1565577A Medicinal capsule of rhubarb horsetails and granule beetle and its preparation method |
01/19/2005 | CN1565569A Processing technique of Aconitum Carrnichaeli Debx |
01/19/2005 | CN1565565A Chinese drugs for treating Hepatitis B and AIDS |
01/19/2005 | CN1565561A Catharsis medicine |
01/19/2005 | CN1565551A Chinese traditional medicine for treating oral disease and its preparing process |
01/19/2005 | CN1565549A Chinese traditional medicine for treating infantile fastidium |
01/19/2005 | CN1565546A Gastrosis treating medicine |
01/19/2005 | CN1565522A Medicine for treating chronic liver disease |
01/19/2005 | CN1565521A Cold treating pills |
01/19/2005 | CN1565517A Preparing method of nanometer level high purity freeze dried powder of aloe and its preparation |
01/19/2005 | CN1565504A Novel |
01/19/2005 | CN1565503A Novel |
01/19/2005 | CN1565502A Novel formulation of 'GuiFu Dihuang' and its preparing method |
01/19/2005 | CN1565501A Novel preparation method of |
01/19/2005 | CN1565494A Chewing tablet of |
01/19/2005 | CN1565485A Brain tonifying and kidney invigorating medicinal capsule |
01/19/2005 | CN1565477A Iodine microsphere clathrate compound and its preparation method and uses |
01/19/2005 | CN1565463A Hepatitis B therapeutic medicine |
01/19/2005 | CN1565440A Silymarin Methylglucamine clathrate compound and its preparation method |
01/19/2005 | CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method |
01/19/2005 | CN1185348C Chimeric interleukin-6 soluble receptor/ligand protein and application thereof |
01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
01/19/2005 | CN1185340C Method for producing medicine using silkworm expressed human alpha2b interferon |
01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
01/19/2005 | CN1185231C Meadowrueleaf corydalis general alkaloid and its prepn and application |
01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
01/19/2005 | CN1185227C Novel compounds |
01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
01/19/2005 | CN1184997C Medicine tablet for treating acute and chronic cholecytitis and cholelithiais and its preparation process |
01/19/2005 | CN1184996C Medicine for treating children diarrhea |
01/19/2005 | CN1184994C Medicine for treating cholelithes and its preparation method |
01/19/2005 | CN1184982C Gastric and duodenum ulcer treating capsule and its preparation |
01/19/2005 | CN1184976C Antilipemic fitness tablet |
01/19/2005 | CN1184970C Oral tablet containing 2-[(4-methoxy-3-methyl)-2-pyridyl]ethylsulfonyl-5-(1-H-pyrrole-1-yl)-1H-benzimidazole |
01/19/2005 | CN1184964C Use of carbonylamino derivatives against CNS disorders |
01/19/2005 | CN1184962C Sertraline oral condensate |
01/19/2005 | CN1184902C Liver-protecting functional food made up by using ligustrum fruit and silkworm chrysalis and its preparation method |
01/18/2005 | US6844457 Antiproliferative agents; anticancer agents; antiinflammatory agents |
01/18/2005 | US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
01/18/2005 | US6844359 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis |
01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
01/18/2005 | US6844332 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
01/18/2005 | US6844331 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
01/18/2005 | US6844330 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-NOR-vitamin D3 and their uses |
01/18/2005 | US6844328 Antiproliferative activity; low systemic toxicity; psoriasis, tumors, rheumatoid arthritis, intestinal inflammation |
01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
01/18/2005 | US6843980 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
01/18/2005 | CA2367127C Macrocyclic peptides active against the hepatitis c virus |
01/13/2005 | WO2005003329A1 Novel galactooligosaccharide composition and the preparation thereof |
01/13/2005 | WO2005003121A1 Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
01/13/2005 | WO2005002606A1 Use of a single-cell protein material |
01/13/2005 | WO2005002593A1 Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
01/13/2005 | WO2005002590A1 Agent inducing increase in bone mass |
01/13/2005 | WO2005002569A1 Pellet preparation of ranitidine |
01/13/2005 | WO2005002563A2 Method for treating alcoholic hepatitis |
01/13/2005 | WO2005002558A1 Preventive and/or therapeutic agent for inflammatory bowel disease |